Angiotensin II, a constrictor and mitogen of vascular smooth muscle cells, affects the release of endothelium-derived factors such as nitric oxide or endothelin-1. This study investigated the influence of endothelin- 1, using the selective endothelin A receptor antagonist LU135252, on blood pressure and endothelial function in angiotensin II-induced hypertension in the rat. Two weeks of angiotensin II administration (200 ng/kg per minute) increased systolic blood pressure (+35+5 min Hg; tail-cuff method) compared with placebo (P
CITATION STYLE
D’Uscio, L. V., Moreau, P., Shaw, S., Takase, H., Barton, M., & Lüscher, T. F. (1997). Effects of chronic ET(A)-receptor blockade in angiotensin II-induced hypertension. Hypertension, 29(1 II), 435–441. https://doi.org/10.1161/01.hyp.29.1.435
Mendeley helps you to discover research relevant for your work.